CELGENE CORP (13) | Business Finance (10)
Browse by Subcategory
Recent Contracts
-
Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,...
(Filed With SEC on November 20, 2019)
-
Asset Purchase Agreement dated August 25, 2019, by and between Celgene Corporation, as seller, and Amgen Inc., as purchaser
(Filed With SEC on August 26, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated October 7, 2010 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 9, 2012 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 6, 2013 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated May 15, 2014 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 12, 2015 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 10, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated November 9, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
(Filed With SEC on July 30, 2019)
-
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated February 20, 2018 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust...
(Filed With SEC on July 30, 2019)